Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell membrane phospholipids and surface anionic groups constitute the fundamental structural and functional barrier of the bacterial cell. Unlike mammalian membranes, which are rich in neutral phospholipids and cholesterol, bacterial membranes contain high proportions of negatively charged lipids such as phosphatidylglycerol and cardiolipin, as well as surface-exposed anionic polymers like lipopolysaccharides in Gram-negative bacteria or teichoic acids in Gram-positive bacteria (Nature Reviews Microbiology, 2017). These components are vital for maintaining the cell's electrochemical gradient, protecting against environmental stressors, and facilitating the assembly of membrane proteins (PubMed, 2021). In clinical medicine, these anionic structures serve as primary targets for several classes of last-resort antibiotics, including polymyxins and lipopeptides. These drugs exploit the charge difference between bacterial and host cells to selectively bind, insert into the membrane, and cause rapid depolarization or physical rupture, leading to bacterial death (NIH, 2022). Understanding these targets is crucial for developing new antimicrobial agents that can overcome increasing rates of antibiotic resistance (StatPearls, 2023).
Drugs targeting these components typically utilize electrostatic attraction to bind to negatively charged surface groups, followed by hydrophobic insertion into the lipid bilayer. This process leads to membrane permeabilization, pore formation, or physical disruption of the membrane, resulting in the leakage of intracellular contents, loss of membrane potential, and eventual cell lysis (StatPearls, 2023; PubMed, 2021).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane phospholipids and surface anionic groups.